Akso Health (AHG) EBIT (2016 - 2019)

Akso Health (AHG) has reported EBIT for 4 consecutive years, with -$10.3 million the latest figure, recorded in Q3 2019.

• For the quarter ending Q3 2019, EBIT rose 41.06% year-over-year to -$10.3 million; the trailing twelve-month figure through Sep 2019 stood at -$31.5 million (down 145.35% YoY), and the FY2026 full-year result was -$20.7 million, up 87.55% from the prior year.
• EBIT slipped to -$10.3 million in Q3 2019 per AHG's latest filing, from -$7.7 million in the prior quarter.
• Across five years, EBIT topped out at $36.1 million in Q2 2018 and bottomed at -$17.5 million in Q3 2018.
• Historically, EBIT has averaged $5.5 million across 4 years, with a median of $2.6 million in 2016.
• The sharpest annual moves came in 2017 and 2018: EBIT jumped 1099.6% in 2017, then slumped 218.92% in 2018.
• Over 4 years, EBIT stood at $2.6 million in 2016, then surged by 1099.6% to $31.6 million in 2017, then slumped by 135.23% to -$11.1 million in 2018, then rose by 7.68% to -$10.3 million in 2019.
• According to Business Quant data, EBIT over the past three periods registered -$10.3 million, -$7.7 million, and -$2.4 million for Q3 2019, Q2 2019, and Q1 2019 respectively.